Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5618
+0.0118 (2.15%)
At close: Aug 15, 2025, 4:00 PM
0.5800
+0.0182 (3.24%)
After-hours: Aug 15, 2025, 5:56 PM EDT

Century Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
4886199303867-
Upgrade
Market Cap Growth
-77.66%-56.77%-34.34%-65.09%--
Upgrade
Enterprise Value
-61-5877-6597-
Upgrade
Last Close Price
0.561.013.325.1315.86-
Upgrade
PS Ratio
0.4213.0388.8858.19--
Upgrade
PB Ratio
0.230.531.081.002.19-
Upgrade
P/TBV Ratio
0.280.681.081.002.19-
Upgrade
P/OCF Ratio
---21.53--
Upgrade
EV/Sales Ratio
--34.33---
Upgrade
Debt / Equity Ratio
0.220.330.260.160.060.29
Upgrade
Asset Turnover
0.330.020.010.01--
Upgrade
Quick Ratio
10.431.479.8110.6114.256.33
Upgrade
Current Ratio
10.721.509.9210.7214.576.51
Upgrade
Return on Equity (ROE)
-10.78%-73.14%-56.07%-37.46%-40.81%-66.45%
Upgrade
Return on Assets (ROA)
-5.27%-23.67%-18.47%-16.75%-21.80%-31.10%
Upgrade
Return on Capital (ROIC)
-6.91%-37.70%-26.75%-20.01%-22.97%-33.63%
Upgrade
Earnings Yield
-48.09%-147.38%-68.80%-43.28%-11.06%-
Upgrade
FCF Yield
--128.42%-51.39%-5.47%-15.46%-
Upgrade
Buyback Yield / Dilution
-29.80%-32.60%-2.70%-78.30%-332.95%-10.43%
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q